SG11201901250PA - Methods and compositions for the treatment of warts - Google Patents
Methods and compositions for the treatment of wartsInfo
- Publication number
- SG11201901250PA SG11201901250PA SG11201901250PA SG11201901250PA SG11201901250PA SG 11201901250P A SG11201901250P A SG 11201901250PA SG 11201901250P A SG11201901250P A SG 11201901250PA SG 11201901250P A SG11201901250P A SG 11201901250PA SG 11201901250P A SG11201901250P A SG 11201901250PA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- international
- pennsylvania
- pct
- warts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662376326P | 2016-08-17 | 2016-08-17 | |
| PCT/US2017/047350 WO2018035328A1 (en) | 2016-08-17 | 2017-08-17 | Methods and compositions for the treatment of warts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201901250PA true SG11201901250PA (en) | 2019-03-28 |
Family
ID=61190995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201901250PA SG11201901250PA (en) | 2016-08-17 | 2017-08-17 | Methods and compositions for the treatment of warts |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20180050009A1 (pt) |
| EP (1) | EP3500274A4 (pt) |
| JP (1) | JP2019524837A (pt) |
| KR (1) | KR20190039575A (pt) |
| CN (1) | CN109862898A (pt) |
| AU (1) | AU2017312047A1 (pt) |
| BR (1) | BR112019003271A2 (pt) |
| CA (1) | CA3033669A1 (pt) |
| MX (1) | MX2019001838A (pt) |
| RU (1) | RU2019107362A (pt) |
| SG (1) | SG11201901250PA (pt) |
| WO (1) | WO2018035328A1 (pt) |
| ZA (1) | ZA201900984B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112016024630B1 (pt) | 2014-04-21 | 2021-02-17 | Aclaris Therapeutics, Inc. | composição tópica e aplicador |
| WO2019232129A1 (en) * | 2018-05-30 | 2019-12-05 | The Board Of Regents Of The University Of Texas System | Treatment of viral infections and virally associated lesions with sequiterpene lactones |
| CN111249306A (zh) * | 2020-01-16 | 2020-06-09 | 刘贤贤 | 一种去除角质的药物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5958984A (en) * | 1996-10-10 | 1999-09-28 | Devillez; Richard L. | Method and composition for skin treatment |
| US6028104A (en) * | 1997-01-30 | 2000-02-22 | Ecolab Inc. | Use of peroxygen compounds in the control of hairy wart disease |
| US20040101571A1 (en) * | 2002-09-11 | 2004-05-27 | Pamela Reed | Use of hydrogen peroxide for the treatment of warts |
| US20080206161A1 (en) * | 2002-10-25 | 2008-08-28 | Dov Tamarkin | Quiescent foamable compositions, steroids, kits and uses thereof |
| BR112016024630B1 (pt) * | 2014-04-21 | 2021-02-17 | Aclaris Therapeutics, Inc. | composição tópica e aplicador |
-
2017
- 2017-08-17 BR BR112019003271A patent/BR112019003271A2/pt not_active IP Right Cessation
- 2017-08-17 CA CA3033669A patent/CA3033669A1/en not_active Abandoned
- 2017-08-17 US US15/679,598 patent/US20180050009A1/en not_active Abandoned
- 2017-08-17 KR KR1020197007691A patent/KR20190039575A/ko unknown
- 2017-08-17 RU RU2019107362A patent/RU2019107362A/ru not_active Application Discontinuation
- 2017-08-17 SG SG11201901250PA patent/SG11201901250PA/en unknown
- 2017-08-17 JP JP2019508972A patent/JP2019524837A/ja active Pending
- 2017-08-17 EP EP17842123.6A patent/EP3500274A4/en not_active Withdrawn
- 2017-08-17 MX MX2019001838A patent/MX2019001838A/es unknown
- 2017-08-17 CN CN201780063270.9A patent/CN109862898A/zh active Pending
- 2017-08-17 AU AU2017312047A patent/AU2017312047A1/en not_active Abandoned
- 2017-08-17 WO PCT/US2017/047350 patent/WO2018035328A1/en unknown
-
2019
- 2019-02-15 ZA ZA2019/00984A patent/ZA201900984B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3500274A4 (en) | 2020-08-12 |
| WO2018035328A1 (en) | 2018-02-22 |
| AU2017312047A1 (en) | 2019-10-17 |
| RU2019107362A (ru) | 2020-09-22 |
| BR112019003271A2 (pt) | 2019-06-04 |
| CN109862898A (zh) | 2019-06-07 |
| ZA201900984B (en) | 2019-12-18 |
| CA3033669A1 (en) | 2018-02-22 |
| US20180050009A1 (en) | 2018-02-22 |
| MX2019001838A (es) | 2019-06-13 |
| JP2019524837A (ja) | 2019-09-05 |
| EP3500274A1 (en) | 2019-06-26 |
| KR20190039575A (ko) | 2019-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201811432WA (en) | Rna for cancer therapy | |
| SG11201909949XA (en) | Targeted immunotolerance | |
| SG11201808990QA (en) | Compositions for topical application of compounds | |
| SG11201811230RA (en) | Compositions and methods for reducing ocular neovascularization | |
| SG11201900163PA (en) | Macrocycle kinase inhibitors | |
| SG11201906386XA (en) | Combination therapy involving diaryl macrocyclic compounds | |
| SG11201810280YA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201900349VA (en) | Somatostatin modulators and uses thereof | |
| SG11201903061YA (en) | Combination treatments comprising administration of imidazopyrazinones | |
| SG11201900554YA (en) | Spiro-lactam nmda modulators and methods of using same | |
| SG11201900551WA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201900546UA (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201900558RA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201901534VA (en) | Combination therapy with controlled-release cnp agonists | |
| SG11201901063SA (en) | Therapeutic agents for neurodegenerative diseases | |
| SG11201903076QA (en) | Carbamoyl phenylalaninol compounds and uses therof | |
| SG11201811351WA (en) | Compositions and methods for forming stable, liquid metal oxide/hydroxide formulations | |
| SG11201901048VA (en) | Pharmaceutical compositions and uses directed to lysosomal storage disorders | |
| SG11201908226XA (en) | Rapamycin analog | |
| SG11201809882XA (en) | Pharmaceutical combinations for treating cancer | |
| SG11201903770UA (en) | Combination treatments comprising imidazopyrazinones for the treatment of psychiatric and/or cognitive disorders | |
| SG11201806480UA (en) | Derivatives of pyrroloimidazole or analogues thereof which are useful for the treatment of inter alia cancer | |
| SG11201900361RA (en) | Methods of treating prostate cancer |